Shareholder Analysis

Significant Shareholdings

As at 1 September 2020, the Company’s issued share capital consists of 215,277,568 ordinary shares with a nominal value of 5p each (“Ordinary Shares”), each share having equal voting rights.

As at 1 September 2020 the Company’s major shareholders are:

Table: “Significant shareholdings”

 

ShareholdersPercentage of shares held
Octopus Investments Limited10.65%
AXA SA6.82%
Canaccord Genuity Group Inc5.54%
Investec Group4.63%
Groupama4.55%
Charles Stanley Group4.34%
Aegon3.37%
Financiere de l’Echiquier3.28%
Aviva plc3.08%

 

In accordance with the AIM Rules (Rule 26), insofar as the Company is aware as at 1 September 2020, the percentage of the Company’s issued share capital that is not in public hands is 12.16%. This percentage consists of the holdings of the directors’ beneficial holdings, the holdings of the AMS Trustee Company in respect of the Company’s Deferred Share Bonus Scheme, and the Company’s substantial shareholders. The Company’s free float is 87.84%.

Any corporate shareholders who wish to contact AMS, or provide information on their shareholding, can send an email to companysecretary@admedsol.com.